Lowering Cholesterol Levels May Worsen Nerve Damage in T2DM
WEDNESDAY, June 5, 2019 -- Lowering serum cholesterol levels in patients with type 2 diabetes is associated with diabetic polyneuropathy (DPN), according to a study published online May 31 in JA
Heritage Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) as a Result of a Sterility Test Failure
Audience: Consumer, Health Pro
FDA Approves Emgality (galcanezumab-gnlm) for the Treatment of Episodic Cluster Headache
INDIANAPOLIS, June 04, 2019 – Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Emgality (galcanezumab-
Exercise, Therapy May Improve Depression, Diabetes Outcomes
FRIDAY, May 31, 2019 -- Exercise and/or behavioral treatment interventions may provide clinically meaningful improvements in depression outcomes in adults with type 2 diabetes (T2DM) and major d
Many Heart Failure Patients Might Safely Reduce Use of Diuretics
FRIDAY, May 31, 2019 -- Heart failure is a common ailment afflicting older Americans, and many take drugs called diuretics to rid the body of excess fluid buildup that can impede breathin
FDA Permits Marketing of Test to Detect Periprosthetic Joint Infection
TUESDAY, May 28, 2019 -- The Synovasure Lateral Flow Test Kit was granted approval for marketing as an aid in detecting periprosthetic joint infection when evaluating patients for rev